Last update:

Allergy and immunology news

Same-day chemotherapy boosts cancer vaccine responses in preclinical models

Both the clinical effects and the unpleasant side effects of chemotherapies, from hair loss to mouth sores to gastrointestinal discomfort, stem from their indiscriminate destruction of cells prone to rapid proliferation. ...

Discovery explains how immune cells target DNA mutations to improve antibodies

Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia, have shed light on a fundamental mystery in immunology: How do immune cells manage to concentrate ...

A new era of discovery for immunology: Expert Q& A

When two people become ill at the same time, they often experience different symptoms. For instance, during the COVID-19 pandemic, some people had symptoms akin to a mild flu, while others were critically ill. Similarly, ...

Researchers discover immune 'off switch' used by cancer cells

Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.

A high-sugar diet may worsen asthma, even in the short term

Sugar consumption has been linked to an increased risk of cavities and weight gain. In the long term, it may also contribute to insulin resistance and diabetes. For people living with asthma, however, the impact can be even ...

Leaky gut might make food allergies worse

A "leaky gut" might increase the severity of food allergies, according to new research conducted in mice and published in The Journal of Immunology. The researchers found that changes to the gut microbiome in mice were linked ...

Long COVID and immune 'soldier' cells: Q&A

Extreme fatigue, a racing pulse, shortness of breath, brain fog, aching joints—the symptoms of long COVID can vary widely, change unpredictably and be difficult to recognize as signs of the condition. Long COVID also remains ...